Track 18: Blood Cancer – Advancing Research, Diagnosis, and Treatment at the 13th International Cancer and Medical Oncology Conference and Exhibition
Blood cancer remains one of the most complex and impactful areas of oncology, affecting the production and function of blood cells and posing significant challenges in diagnosis, treatment, and long-term patient care. Track 18: Blood Cancer at the 13th International Cancer and Medical Oncology Conference and Exhibition , taking place on February 1–2, 2027 at Novotel Al Barsha, Dubai, UAE , is designed to bring together hematologists, oncologists, researchers, clinicians, academicians, and healthcare innovators to discuss the latest breakthroughs in hematologic malignancies and precision oncology. The conference offers participants a global platform for scientific exchange, networking, and professional development, along with eligibility for 30 CME/CPD Credits for qualified attendees. About Track 18: Blood Cancer Track 18 focuses on cancers that affect the blood, bone marrow, and lymphatic system, including: Leukemia Lymphoma Multiple Myeloma Myelodysplastic Syndromes Myelopro...